Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...

The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...

French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham.

Genzyme of Cambridge, Massachusetts, faces millions in lost revenue from its top-selling specialty drugs Cerezyme and Fabrazyme as result of a viral contamination at its Allston, Massachusetts plant.

The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...

Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling. Net sales were €8,391 million ...

Genzyme Corp. (Sanofi Genzyme) has disclosed sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, among others.

OmnifitToms River, NJ Circle No. 103 on Reader Service Card Four new Cytokine ELISA Kits have been added to Genzyme's line of cytokine research products. The Predicta IL-10 ELISA Kit is designed for ...

Led by new CEO James Sherblom, formerly of Genzyme Corp., the firm aims to raise $5 million and augment its scientific staff as a result of the initial public offering it expects to complete in the ...

Since April 2011, he has also been the Chairman of Genzyme. In 2011, net sales reached €33,389 million, +3.2% on a reported basis, +5.3% at constant exchange rates (CER) versus 2010. Sanofi has ...

JMB is a part-time employee of the NHL. JMB’s institution has received funding from Genzyme and EyeGuide supporting his work, and he has served as a paid consultant to Med-IQ and Sporting KC.